HIT Consultant March 19, 2025
What You Should Know:
– Tandem Diabetes Care, a leader in insulin delivery and diabetes technology announced the U.S. commercial launch of Control-IQ+ technology.
– This update provides users with greater flexibility and control over their diabetes management. The expanded parameters and enhanced features of Control-IQ+ are designed to address a broader range of individual needs, making automated insulin delivery more accessible and effective.
Automated Insulin Delivery Technology
Control-IQ+ is compatible with both the t:slim X2 insulin pump and the Tandem Mobi System, and is now available for individuals with type 1 diabetes ages 2 years and older, as well as adults with type 2 diabetes. New pumps pre-loaded with the updated software are now being shipped...
Today's Sponsors
Today's Sponsor